115 related articles for article (PubMed ID: 10935472)
1. Mutation and expression of the p51 gene in human lung cancer.
Tani M; Shimizu K; Kawahara C; Kohno T; Ishimoto O; Ikawa S; Yokota J
Neoplasia; 1999 Apr; 1(1):71-9. PubMed ID: 10935472
[TBL] [Abstract][Full Text] [Related]
2. Absence of p51 alteration in human ovarian cancer.
Shinozaki H; Okamoto A; Shimizu K; Saito M; Yokota J; Ochiai K
Int J Oncol; 2001 Mar; 18(3):549-52. PubMed ID: 11179485
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer.
Sunahara M; Shishikura T; Takahashi M; Todo S; Yamamoto N; Kimura H; Kato S; Ishioka C; Ikawa S; Ikawa Y; Nakagawara A
Oncogene; 1999 Jun; 18(25):3761-5. PubMed ID: 10391684
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of the p51 gene and correlation between p53, p73, and p51 expressions in prostatic carcinoma.
Takahashi H; Fukutome K; Watanabe M; Furusato M; Shiraishi T; Ito H; Suzuki H; Ikawa S; Hano H
Prostate; 2001 May; 47(2):85-90. PubMed ID: 11340630
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional dysregulation of the p73L / p63 / p51 / p40 / KET gene in human squamous cell carcinomas: expression of Delta Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p51.
Senoo M; Tsuchiya I; Matsumura Y; Mori T; Saito Y; Kato H; Okamoto T; Habu S
Br J Cancer; 2001 May; 84(9):1235-41. PubMed ID: 11336476
[TBL] [Abstract][Full Text] [Related]
6. Absence of p51 mutation in human hepatocellular carcinoma.
Hamada K; Koyama T; Shimizu K; Ikawa S; Kawate S; Yokota J; Ohwada S; Morishita Y
Cancer Lett; 2000 Feb; 148(2):161-4. PubMed ID: 10695992
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated transfer of p53-related genes induces apoptosis of human cancer cells.
Ishida S; Yamashita T; Nakaya U; Tokino T
Jpn J Cancer Res; 2000 Feb; 91(2):174-80. PubMed ID: 10761704
[TBL] [Abstract][Full Text] [Related]
8. Mutation of the p51/p63 gene is associated with blastic crisis in chronic myelogenous leukemia.
Yamaguchi H; Inokuchi K; Sakuma Y; Dan K
Leukemia; 2001 Nov; 15(11):1729-34. PubMed ID: 11681414
[TBL] [Abstract][Full Text] [Related]
9. Evolutionarily conserved expression pattern and trans-regulating activity of Xenopus p51/p63.
Tomimori Y; Katoh I; Kurata S; Okuyama T; Kamiyama R; Ikawa Y
Biochem Biophys Res Commun; 2004 Jan; 313(2):230-6. PubMed ID: 14684151
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of the putative tumor-suppressor genes DCC, p51/63 and O6-methylguanine-DNA methyltransferase (MGMT) and loss of their expressions in cell lines of hematological malignancies.
Nakayama K; Inokuchi K; Dan K
J Nippon Med Sch; 2005 Oct; 72(5):270-7. PubMed ID: 16247226
[TBL] [Abstract][Full Text] [Related]
11. E1B 55-kilodalton oncoproteins of adenovirus types 5 and 12 inactivate and relocalize p53, but not p51 or p73, and cooperate with E4orf6 proteins to destabilize p53.
Wienzek S; Roth J; Dobbelstein M
J Virol; 2000 Jan; 74(1):193-202. PubMed ID: 10590106
[TBL] [Abstract][Full Text] [Related]
12. The expression of p73 is increased in lung cancer, independent of p53 gene alteration.
Tokuchi Y; Hashimoto T; Kobayashi Y; Hayashi M; Nishida K; Hayashi S; Imai K; Nakachi K; Ishikawa Y; Nakagawa K; Kawakami Y; Tsuchiya E
Br J Cancer; 1999 Jul; 80(10):1623-9. PubMed ID: 10408409
[TBL] [Abstract][Full Text] [Related]
13. p53 family genes: structural comparison, expression and mutation.
Ikawa S; Nakagawara A; Ikawa Y
Cell Death Differ; 1999 Dec; 6(12):1154-61. PubMed ID: 10637430
[TBL] [Abstract][Full Text] [Related]
14. Analysis of molecular interactions of the p53-family p51(p63) gene products in a yeast two-hybrid system: homotypic and heterotypic interactions and association with p53-regulatory factors.
Kojima T; Ikawa Y; Katoh I
Biochem Biophys Res Commun; 2001 Mar; 281(5):1170-5. PubMed ID: 11243857
[TBL] [Abstract][Full Text] [Related]
15. Quantitative TP73 transcript analysis in hepatocellular carcinomas.
Stiewe T; Tuve S; Peter M; Tannapfel A; Elmaagacli AH; Pützer BM
Clin Cancer Res; 2004 Jan; 10(2):626-33. PubMed ID: 14760085
[TBL] [Abstract][Full Text] [Related]
16. Cloning and functional analysis of human p51, which structurally and functionally resembles p53.
Osada M; Ohba M; Kawahara C; Ishioka C; Kanamaru R; Katoh I; Ikawa Y; Nimura Y; Nakagawara A; Obinata M; Ikawa S
Nat Med; 1998 Jul; 4(7):839-43. PubMed ID: 9662378
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of the p63/p73L/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers.
Hagiwara K; McMenamin MG; Miura K; Harris CC
Cancer Res; 1999 Sep; 59(17):4165-9. PubMed ID: 10485447
[TBL] [Abstract][Full Text] [Related]
18. p53CP is p51/p63, the third member of the p53 gene family: partial purification and characterization.
Tan M; Bian J; Guan K; Sun Y
Carcinogenesis; 2001 Feb; 22(2):295-300. PubMed ID: 11181451
[TBL] [Abstract][Full Text] [Related]
19. Mutation and transcription analyses of the p63 gene in cervical carcinoma.
Nishi H; Isaka K; Sagawa Y; Usuda S; Fujito A; Ito H; Senoo M; Kato H; Takayama M
Int J Oncol; 1999 Dec; 15(6):1149-53. PubMed ID: 10568821
[TBL] [Abstract][Full Text] [Related]
20. Infrequent somatic mutations of the p73 gene in various human cancers.
Han S; Semba S; Abe T; Makino N; Furukawa T; Fukushige S; Takahashi H; Sakurada A; Sato M; Shiiba K; Matsuno S; Nimura Y; Nakagawara A; Horii A
Eur J Surg Oncol; 1999 Apr; 25(2):194-8. PubMed ID: 10218465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
